A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995

The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product

Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017

Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53

Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456

Cyclin is degraded by the ubiquitin pathway

Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,359

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403

Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response

Wendel, S. O., & Wallace, N. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02250 · Cited by 41

Rodent Papillomaviruses

Uberoi, A., & Lambert, P. F. (2017) · Viruses · doi:10.3390/v9120362 · Cited by 41

A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves motor functions in Angelman syndrome mice

Li, J., Shen, Z., Liu, Y., Yan, Z., Liu, Y., Lin, X., Tang, J., Lv, R., Geng, G., Xiong, Z., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.015 · Cited by 40

Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis

Simmonds, M., & Storey, A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23815 · Cited by 39

HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1

Wang, Q., Song, R., Zhao, C., Liu, H., Yang, Y., Gu, S., Feng, D., & He, J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31876 · Cited by 38

Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology

Kim, Y. J., Kim, M., Park, H. K., Yu, D. B., Jung, K., Song, K., & Choi, Y. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0263-4 · Cited by 38

Prader-Willi syndrome: reflections on seminal studies and future therapies

Chung, M. S., Langouët, M., Chamberlain, S. J., & Carmichael, G. (2020) · Open Biology · doi:10.1098/rsob.200195 · Cited by 39

A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells

Ristriani, T., Fournane, S., Orfanoudakis, G., Travé, G., & Masson, M. (2008) · Oncogene · doi:10.1038/onc.2008.422 · Cited by 38

Combining metabolic fingerprinting and footprinting to understand the phenotypic response of HPV16 E6 expressing cervical carcinoma cells exposed to the HIV anti-viral drug lopinavir

Kim, D., Jarvis, R. M., Yun Xu, A., Oliver, A. W., Allwood, J. W., Hampson, L., HAMPSON, I. N., & Goodacre, R. (2010) · The Analyst · doi:10.1039/b923046g · Cited by 38

The Structure of the Vertebrate Lens

Kuszak, J. R., & Costello, M. J. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.005 · Cited by 38

HPV 16 E6 Blocks TNF-Mediated Apoptosis in Mouse Fibroblast LM Cells

Duerksen-Hughes, P. J., Yang, J. J., & Schwartz, S. B. (1999) · Virology · doi:10.1006/viro.1999.9977 · Cited by 38

Advances in the development of therapeutic nucleic acids against cervical cancer

DiPaolo, J. A., & Álvarez-Salas, L. M. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.8.1251 · Cited by 38

The role of p53 inactivation in human cervical cell carcinoma development

Miwa, K., Miyamoto, S., Kato, H., Imamura, T., Nishida, M., Yoshikawa, Y., Nagata, Y., & Wake, N. C. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.47 · Cited by 38

Targeting the Ubiquitin System in Glioblastoma

Scholz, N., Kurian, K. M., Siebzehnrübl, F. A., & Licchesi, J. D. F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.574011 · Cited by 37

Nuclear Receptor Coregulators Are New Players in Nervous System Development and Function

Nishihara, E., O’Malley, B. W., & Xu, J. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:3:307 · Cited by 37

Role for PP2A in ARF signaling to p53

Moule, M. G., Collins, C. H., McCormick, F. P., & Fried, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405533101 · Cited by 37

The p53 tumor suppressor gene

Soussi, T. (1995) · Advances in genome biology · doi:10.1016/s1067-5701(06)80005-7 · Cited by 37

Molecular Biology of Human Papillomavirus Infection and Oncogenesis

Androphy, E. J. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12393230 · Cited by 37

HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells

Liu, C., Lin, J., Li, L., Zhang, Y., Chen, W., Cao, Z., Zuo, H., Chen, C., & Kee, K. (2015) · Scientific Reports · doi:10.1038/srep07653 · Cited by 36

Failure of viral oncoproteins to target the p53-homologue p51A

Roth, J. C., & Dobbelstein, M. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-12-3251 · Cited by 36

E3 ubiquitin protein ligase, E6-associated protein (E6-AP) regulates PI3K-Akt signaling and prostate cell growth

Srinivasan, S., & Nawaz, Z. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.08.011 · Cited by 35

The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation

Shimada, M., Yamashita, A., Saito, M., Ichino, M., Kinjo, T., Mizuki, N., Klinman, D. M., & Okuda, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-71134-3 · Cited by 34

RU486 Increases Radiosensitivity and Restores Apoptosis through Modulation of HPV E6/E7 in Dexamethasone-Treated Cervical Carcinoma Cells

Kamradt, M. C., Mohideen, N., & Vaughan, A. T. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5724 · Cited by 35

Inhibition of Serum- and Calcium-Induced Terminal Differentiation of Human Keratinocytes by HPV 16 E6: Study of the Association with p53 Degradation, Inhibition of p53 Transactivation, and Binding to E6BP

Sherman, L., Itzhaki, H., Jackman, A., Chen, J. J., Koval, D., & Schlegel, R. (2002) · Virology · doi:10.1006/viro.2001.1263 · Cited by 35

Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation

Gardiol, D., Galizzi, S., & Banks, L. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-2-283 · Cited by 35

Biological Activities of p53 Mutants in Burkitt's Lymphoma Cells

Vousden, K. H., Farrell, P. J., & Crook, T. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-5-803 · Cited by 35

The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus

Chalma, P. R., Antonio-Véjar, V., Tejedor, J. G. O., Ortíz, J., Vega, B., & Ordóñez, G. D. B. (2024) · Biology · doi:10.3390/biology13020077 · Cited by 35

HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition

Wallace, N. A., Gasior, S. L., Faber, Z. J., Howie, H. L., Deininger, P. L., & Galloway, D. A. (2013) · Virology · doi:10.1016/j.virol.2013.04.022 · Cited by 37

Isoform-Specific Degradation of PR-B by E6-AP Is Critical for Normal Mammary Gland Development

Ramamoorthy, S., Dhananjayan, S. C., DeMayo, F. J., & Nawaz, Z. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0116 · Cited by 34

The role of E3 ubiquitin ligases in synapse function in the healthy and diseased brain

Kawabe, H., & Stegmüller, J. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103602 · Cited by 33

Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High‐Affinity Bivalent Ligand

Ramirez, J., Poirson, J., Foltz, C., Chebaro, Y., Schrapp, M., Meyer, A., Bonetta, A., Forster, A., Jacob, Y., Masson, M., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201502646 · Cited by 34

Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV+ cells

Ch, Y., Filippova, M., Krstenansky, J. L., & Duerksen-Hughes, P. J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.391 · Cited by 34

p53 codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours

Sourvinos, G., Rizos, E., & Spandidos, D. A. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00139-1 · Cited by 34

Degradation of p53, Not Telomerase Activation, by E6 Is Required for Bypass of Crisis and Immortalization by Human Papillomavirus Type 16 E6/E7

McMurray, H. R., & McCance, D. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5698-5706.2004 · Cited by 35

VCY2 protein interacts with the HECT domain of ubiquitin-protein ligase E3A

Wong, E. Y. M., Tse, J. Y. M., Yao, K., Tam, P., & Yeung, W. S. B. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02040-5 · Cited by 34

Mechanism of p53 degradation

Brown, J. P., & Pagano, M. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00048-0 · Cited by 34

Molecular biomarkers in cervical cancer diagnosis: a critical appraisal

Litjens, R. J. N. T. M., Hopman, A. H. N., de Vijver, K. K. V., Ramaekers, F. C. S., Kruitwagen, R. F. P. M., & Kruse, A. (2013) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.808621 · Cited by 33

A small molecule directly inhibits the p53 transactivation domain from binding to replication protein A

Glanzer, J. G., Carnes, K. A., Soto, P., Liu, S., Parkhurst, L. J., & Oakley, G. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1291 · Cited by 33

The Genomics, Epigenomics, and Transcriptomics of HPV-Associated Oropharyngeal Cancer—Understanding the Basis of a Rapidly Evolving Disease

Lechner, M., & Fenton, T. R. (2016) · Advances in genetics · doi:10.1016/bs.adgen.2015.12.001 · Cited by 34

Dosage-sensitive genes in autism spectrum disorders: From neurobiology to therapy

Javed, S., Selliah, T., Lee, Y., & Huang, W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.009 · Cited by 32

Regulation of apoptosis by the papillomavirus E6 oncogene

Li, T. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i7.931 · Cited by 33

Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins

Pim, D., Thomas, M., & Banks, L. (2002) · Oncogene · doi:10.1038/sj.onc.1206026 · Cited by 33

Natural Substrates of the Proteasome and Their Recognition by the Ubiquitin System

Ulrich, H. D. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59414-4_6 · Cited by 33

Involvement of the proteasome and antizyme in ornithine decarboxylase degradation by a reticulocyte lysate

Murakami, Y., Matsufuji, S., Tanaka, K., Ichihara, A., & Hayashi, S. (1993) · Biochemical Journal · doi:10.1042/bj2950305 · Cited by 33

The Ubiquitin-Conjugation System

Scheffner, M., Smith, S. H., & Jentsch, S. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1922-9_3 · Cited by 34

Human Papillomavirus Type 16 E6/E7 Upregulation of Nucleophosmin Is Important for Proliferation and Inhibition of Differentiation

McCloskey, R., Menges, C. W., Friedman, A. E., Patel, D., & McCance, D. J. (2010) · Journal of Virology · doi:10.1128/jvi.01965-09 · Cited by 32

Selective multifaceted E3 ubiquitin ligases barricade extreme defense: Potential therapeutic targets for neurodegeneration and ageing

Upadhyay, A., Amanullah, A., Chhangani, D., Mishra, R., & Mishra, A. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.009 · Cited by 33

Epigenetics of oral and oropharyngeal cancers (Review)

Russo, D., Merolla, F., Varricchio, S., Salzano, G., Zarrilli, G., Mascolo, M., Strazzullo, V., Crescenzo, R. M. D., Celetti, A., & Ilardi, G. (2018) · Biomedical Reports · doi:10.3892/br.2018.1136 · Cited by 32

Ubiquitination at the interface of tumor viruses and DNA damage responses

Dybas, J. M., Herrmann, C., & Weitzman, M. D. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.08.017 · Cited by 31

Mutation screening and association study of the UBE2H gene on chromosome 7q32 in autistic disorder

Vourc’h, P., Martin, I., Bonnet‐Brilhault, F., Marouillat, S., Barth�l�my, C., Müh, J. P., & Andres, C. R. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200312000-00005 · Cited by 32

P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population

Shao, Y., Tan, W., & Zhang, S. (2007) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2007.00746.x · Cited by 32

Human Papilloma Virus (HPV) E7-Mediated Attenuation of Retinoblastoma (Rb) Induces hPygopus2 Expression via Elf-1 in Cervical Cancer

Tzenov, Y. R., Andrews, P., Voisey, K., Popadiuk, P., Xiong, J., Popadiuk, C., & Kao, K. R. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0510 · Cited by 32

Activation of telomerase by HPVs

Katzenellenbogen, R. A. (2016) · Virus Research · doi:10.1016/j.virusres.2016.11.003 · Cited by 32

Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6

Matsumoto, Y., Nakagawa, S., Yano, T., Takizawa, S., Nagasaka, K., Nakagawa, K., Minaguchi, T., Wada, O., Ooishi, H., Matsumoto, K., et al. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20568 · Cited by 34

Hot-Spot p53 Mutants Interact Specifically with Two Cellular Proteins during Progression of the Cell Cycle

Chen, Y., Chen, P., & Lee, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6764 · Cited by 32

Thiothymidine plus low-dose UVA kills hyperproliferative human skin cells independently of their human papilloma virus status

Reelfs, O., Xu, Y.-Z., Massey, A., Karran, P., & Storey, A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0166 · Cited by 30

HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins

Park, S., Auyeung, A. S., Lee, D. L., Lambert, P. F., Carchman, E. H., & Sherer, N. M. (2021) · Cancers · doi:10.3390/cancers13050949 · Cited by 31

Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer

Han, M.-S., Lee, J. M., Kim, S., Kim, J., & Kim, H.-S. (2018) · BioMed Research International · doi:10.1155/2018/1942867 · Cited by 31

Interactome analysis of gene expression profiles of cervical cancer reveals dysregulated mitotic gene clusters.

Cheng, J., Lu, X., Wang, J., Zhang, H., Duan, P., & Li, C. (2017) · PubMed Central · Cited by 31

Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells.

Daniels, P. R., Maitland, N. J., & Sanders, C. M. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-3-489 · Cited by 31

Advances in understanding the mechanisms of the human papillomavirus oncoproteins

Obanya, D. I., Wootton, L. M., & Morgan, E. L. (2025) · Biochemical Society Transactions · doi:10.1042/bst20253041 · Cited by 30

High-Risk Human Papillomavirus E6 Protein Promotes Reprogramming of Fanconi Anemia Patient Cells through Repression of p53 but Does Not Allow for Sustained Growth of Induced Pluripotent Stem Cells

Chlon, T. M., Hoskins, E. E., Mayhew, C. N., Wikenheiser‐Brokamp, K. A., Davies, S. M., Mehta, P. A., Myers, K. C., Wells, J. M., & Wells, S. I. (2014) · Journal of Virology · doi:10.1128/jvi.01533-14 · Cited by 30

Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy

Carobeli, L. R., Meirelles, L. E. D. F., Damke, G. M. Z. F., Damke, E., de Souza, M. V. F., Mari, N. L., Mashiba, K. H., Mesquita, C. S. S., Souza, R. P., da Silva, V. R. S., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122057 · Cited by 31

Down-regulation of p21 contributes to apoptosis induced by HPV E6 in human mammary epithelial cells

Fan, X., Liu, Y., & Chen, J. J. (2005) · APOPTOSIS · doi:10.1007/s10495-005-6062-y · Cited by 30

Modulation of the ARF-p53 Pathway by the Small DNA Tumor Viruses

O’Shea, C. C., & Fried, M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1555 · Cited by 29

HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP

Shai, A., Nguyen, M.-L., Wagstaff, J., Jiang, Y.-H., & Lambert, P. F. (2006) · Oncogene · doi:10.1038/sj.onc.1210130 · Cited by 30

IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced Mitogenesis

Baege, A. C., Disbrow, G. L., & Schlegel, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5720-5727.2004 · Cited by 30

The tumor immune microenvironments of HPV + and HPV − head and neck cancers

Gameiro, S. F., Evans, A. M., & Mymryk, J. S. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1539 · Cited by 32

A Critical Role for p53 during the HPV16 Life Cycle

Fontan, C. T., James, C. D., Bristol, M. L., Prabhakar, A. T., Otoa, R. O., Wang, X., Karimi, E., Rajagopalan, P., Basu, D., & Morgan, I. M. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00681-22 · Cited by 30

The DNA Damage Response Kinases DNA-dependent Protein Kinase (DNA-PK) and Ataxia Telangiectasia Mutated (ATM) Are Stimulated by Bulky Adduct-containing DNA

Kemp, M. G., Lindsey‐Boltz, L. A., & Sancar, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.235036 · Cited by 30

The Human Papillomavirus E6 PDZ Binding Motif Links DNA Damage Response Signaling to E6 Inhibition of p53 Transcriptional Activity

Thatte, J. V., Massimi, P., Thomas, M., Boon, S. S., & Banks, L. (2018) · Journal of Virology · doi:10.1128/jvi.00465-18 · Cited by 29

Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance

Venuti, A., Lohse, S., Tommasino, M., & Smola, S. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0287 · Cited by 31

Multiple genetic loci modify risk for retinoblastoma in transgenic mice.

Griep, A. E., Krawcek, J., Lee, D., Liem, A., Albert, D. M., Carabeo, R. A., Drinkwater, N. R., McCall, M. A., Sattler, C. A., Lasudry, J., et al. (1998) · PubMed · Cited by 29

Epidemiology of Human Papilloma Virus (HPV) in Cervical Mucosa

Chauhan, S. C., Jaggi, M., Bell, M. C., Verma, M., & Kumar, D. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-416-2_22 · Cited by 29

P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility

Hou, J., Gu, Y., Hou, W., Wu, S., Lou, Y., Yang, W., Zhu, L. Y., Hu, Y., Sun, M., & Xue, H. (2015) · BMC Genetics · doi:10.1186/s12863-015-0235-7 · Cited by 28

Molecular mechanisms of hyperplasia induction by human papillomavirus E7

Ueno, T., Sasaki, K., Yoshida, S., Kajitani, N., Satsuka, A., Nakamura, H., & Sakai, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209445 · Cited by 28

Inactivation of p53 Rescues the Maintenance of High Risk HPV DNA Genomes Deficient in Expression of E6

Lorenz, L. D., Cardona, J. R., & Lambert, P. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003717 · Cited by 28

p53 polymorphism in human papillomavirus-associated Kazakh’s esophageal cancer in Xinjiang, China

Lu, X. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i19.2775 · Cited by 28

p53 and hTERT Determine Sensitivity to Viral Apoptosis

Nguyen, M. L., Kraft, R. M., Aubert, M., Goodwin, E. C., DiMaio, D., & Blaho, J. A. (2007) · Journal of Virology · doi:10.1128/jvi.01485-07 · Cited by 28

The Roles of E6-AP and MDM2 in p53 Regulation in Human Papillomavirus-Positive Cervical Cancer Cells

Chomnawang, M. T., Chen, L., Yu, D. S., Agrawal, S., & CHEN, J. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.17 · Cited by 28

Identification of a Region of p53 That Confers Lability

Li, X., & Coffino, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4447 · Cited by 28

The Role of HECT-Type E3 Ligase in the Development of Cardiac Disease

Goto, J., Otaki, Y., Watanabe, T., & Watanabe, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116065 · Cited by 26

In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein

Moujane, S., Hajji, H., khatabi, K. E., Mzibri, M. E., Younesd, F. Z., Mohammed, B., Mohameda, B., & Benaissa, M. (2022) · Vaccines · doi:10.3390/vaccines10091452 · Cited by 28

Human papillomavirus early proteins and apoptosis

Cai, Q., Lv, L., Shao, Q., Li, X., & Dian, A. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2665-z · Cited by 31

Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations

Wen, X., Li, D., Zhang, Y., Liu, S., Ghali, L. R., & Iles, R. K. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834f1fd3 · Cited by 27

Site-specific comparison of p53 immunostaining in squamous cell carcinomas

Coulter, L. K., Wolber, R. A., & Tron, V. A. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90249-x · Cited by 27

Is the DNA repair system involved in hepatitis-B-virus-mediated hepatocellular carcinogenesis?

Butel, J. S., Lee, T.-H., & Slagle, B. L. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)81529-0 · Cited by 27

Requirement of E7 oncoprotein for viability of HeLa cells

Nishimura, A., Nakahara, T., Ueno, T., Sasaki, K., Yoshida, S., Kyo, S., Howley, P. M., & Sakai, H. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.10.015 · Cited by 27

Structural insights into the functional mechanism of the ubiquitin ligase E6AP

Wang, Z., Fan, F., Li, Z., Ye, F., Wang, Q., Gao, R., Qiu, J., Lv, Y., Lin, M., Xu, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47586-w · Cited by 29

UBE3A regulates the transcription of IRF, an antiviral immunity

Furumai, R., Tamada, K., Liu, X., & Takumi, T. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz019 · Cited by 26

HPV16 E6 induces chromosomal instability due to polar chromosomes caused by E6AP-dependent degradation of the mitotic kinesin CENP-E

Cosper, P. F., Hrycyniak, L., Paracha, M., Lee, D. L., Wan, J., Jones, K. M., Bice, S. A., Nickel, K. P., Mallick, S., Taylor, A. M., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216700120 · Cited by 25

Expression of the different viral mRNAs of human papilloma virus 6 in a squamous‐cell carcinoma of the bladder and the cervix

Oft, M., Böhm, S. K., Iftner, T., & Wilczynski, S. P. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530610 · Cited by 26

Degradation of p53 by natural variants of the E6 protein of human papillomavirus type 16

Yi, J., Jang, M., Kim, S. J., Kim, S. S., & Rhee, J. E. (2013) · Oncology Reports · doi:10.3892/or.2013.2281 · Cited by 25

Prophylactic papillomavirus vaccines

Ribeiro-Müller, L., & Müller, M. (2014) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2013.08.008 · Cited by 27

Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity

Drews, C. M., Brimer, N., & Pol, S. V. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008295 · Cited by 25

Epstein‐Barr virus‐encoded EBNA‐5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53

Kashuba, E., Yurchenko, M., Yenamandra, S. P., Снопок, Б. А., Székely, L., Bercovich, B., Ciechanover, A. J., & Klein, G. (2010) · International Journal of Cancer · doi:10.1002/ijc.25414 · Cited by 28

Growth Factors in Lens Development

Lang, R. A., & McAvoy, J. W. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.012 · Cited by 25

The characterisation of p53 binding phage isolated from phage peptide display libraries

Daniels, D. A., & Lane, D. P. (1994) · Journal of Molecular Biology · doi:10.1016/0022-2836(94)90038-8 · Cited by 25

A Humanized Mouse Model of HPV-Associated Pathology Driven by E7 Expression

Buitrago-Pérez, Á., Hachimi, M., Dueñas, M., Lloveras, B., Santos, A., Holguín, A., Duarte, B., Santiago, J. L., Akgũl, B., Rodríguez‐Peralto, J. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041743 · Cited by 26

The Differentiation-Dependent Life Cycle of Human Papillomaviruses in Keratinocytes

Lee, C., & Laimins, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-36523-7_4 · Cited by 24

Cloning and Expression of the cDNA for E6-AP, a Protein that Mediates the Interaction of the Human Papillomavirus E6 Oncoprotein with p53

Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.775 · Cited by 553

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416

Interaction of the E6 protein of human papillomavirus with cellular proteins.

Keen, N., Elston, R., & Crawford, L. (1994) · PubMed · Cited by 53

The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells

Talis, A. L., Huibregtse, J. M., & Howley, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6439 · Cited by 261

Requirement of e6ap and the features of human papillomavirus e6 necessary to support degradation of p53

Cooper, B., Schneider, S., Bohl, J., Jiang, Y.-H., Beaudet, A. L., & Pol, S. V. (2003) · Virology · doi:10.1016/s0042-6822(02)00012-0 · Cited by 86